Zantac makers handed court win in Delaware

4 hours ago 1

Healthcare

The Delaware Supreme Court ruled in favor of companies including GSK (NYSE:GSK), Pfizer (NYSE:PFE), and Boehringer Ingelheim on Thursday, rejecting the legitimacy of expert testimony that linked tens of thousands of cancer cases to the heartburn drug Zantac.

The state’s

Recommended For You

More Trending News

Read Entire Article

Zantac makers handed court win in Delaware

Recommended For You

More Trending News

Related

Newegg Commerce's FantasTech Sale fuels 4-day rally

Americans are eyeing up €1 homes in Europe to escape the bro...

Seeking Alpha's top Quant picks in Utilities sector as Q2 ea...

Nvidia CEO Jensen Huang sells over $36M in stock, catching u...

Agenus unit, MiNK surges after peer-reviewed data for lead d...

Pure Storage's design win with Meta might lead to catalyst: ...

Trump is ‘extremely troubled’ by Fed’s approach according to...

Seeking Alpha's top Quant picks in Communication Services se...

Stocks to watch: Seeking Alpha’s top Materials quant picks a...

Bitcoin scores an all-time high, blowing past $118,000 for t...

Walgreens shareholders approve Sycamore's deal proposal

Mark Zuckerberg is determined to build an AI superteam—and h...

Above Food stock soars 178% on merger with Palm Global, push...

Indeed and Glassdoor are cutting over 1,000 jobs. The CEO ov...

Harrow jumps as Cantor initiates with Bullish view on conser...

Oscar Health cut to UnderWeight at Wells Fargo on pricing co...

Delta repurposes Airbus engines amid trade dispute and jet s...

Panasonic to delay full production at Kansas EV battery plan...

U.S. stocks dip after back-to-back record closes as Trump ta...

Needham gives Netflix a chunky PT hike and maintains 'buy'

Trending

Popular

TechCrunch Mobility: The state of EV sales and Rivian secure...

Castelion raises $350M Series B to scale hypersonic missile ...